Results 191 to 200 of about 106,545 (283)

The Molecular Mechanisms of Imatinib Treatment on Acute Lung Injury in Septic Mice Through Proteomic Technology. [PDF]

J Immunol Res
Wang X, Zhou Z, Li D, Zhang B, Zong X, Liang X, Li Z.   +6 more
europepmc   +1 more source

BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells [PDF]

, 2003
Su Chu, Melissa Holtz, Mamta Gupta, Ravi Bhatia   +3 more
openalex   +1 more source

Comparative Clinical Outcomes and Safety of Generic Versus Original Imatinib in the Treatment of Chronic Myeloid Leukemia: A Real-World Cohort Study from Thailand. [PDF]

J Clin Med
Tangkitchot J, Tantiworawit A, Niprapan P, Wongsarikan N, Srichairatanakool S, Punnachet T, Hantrakun N, Piriyakhuntorn P, Rattanathammethee T, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Hantrakool S.   +12 more
europepmc   +1 more source

Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome [PDF]

, 2003
Jorge E. Cortés, Patricia Ault, Charles Koller, Deborah Thomas, Alessandra Ferrajoli, William G. Wierda, Mary Beth Rios, Laurie Letvak, Elizabeth S. Kaled, Hagop M. Kantarjian   +9 more
openalex   +1 more source

Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571) [PDF]

, 2003
Lara Wohlbold, Heiko van der Kuip, Cornelius Miething, Hans‐Peter Vornlocher, Cornelius Knabbe, Justus Duyster, Walter E. Aulitzky   +6 more
openalex   +1 more source

Real-world evidence of imatinib treatment in younger and older patients with chronic myeloid leukaemia: A retrospective single centre analysis. [PDF]

Oncol Lett
Graf R, Kreye G, Pecherstorfer M, Singer J.   +3 more
europepmc   +1 more source

Gynaecomastia in men with chronic myeloid leukaemia after imatinib [PDF]

, 2003
Carlo Gambacorti‐Passerini, Lucia Tornaghi, Francesco Cavagnini, Pellegrino Rossi, Francesca Pecori‐Giraldi, Luigi Mariani, Nadia Cambiaghi, Enrico Pogliani, Gianmarco Corneo, Lucio Gnessi   +9 more
openalex   +1 more source

Divergent gene expression of <i>PTGS1</i> and <i>PTGS2</i> along the disease course of chronic myeloid leukaemia. [PDF]

Front Oncol
Wosniaki DK, Kusma BN, Marin AM, Munhoz EC, Farias JSH, Mendes EB, Aoki MN, Zanette DL.   +7 more
europepmc   +1 more source

Another Act in the Story of Oral Imatinib for Pulmonary Arterial Hypertension. [PDF]

Am J Respir Crit Care Med
Gomberg-Maitland M, Souza R.
europepmc   +1 more source

Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta [PDF]

, 2003
Juan Luis Garcı́a, Jaime Font de Mora, Jesús María Hernández‐Rivas, José Antonio Queizán, Norma C. Gutiérrez, José M. Hernández, Jesús F. San Miguel   +6 more
openalex   +1 more source